SCIESCOPUSQ3
Immunotherapy
TAYLOR & FRANCIS LTD, United Kingdom
Immunotherapy is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1750-743X, eISSN 1750-7448. Indexed in SCIE, SCOPUS. Metrics: JIF 2.3, CiteScore 4.9, SJR 0.835, SNIP 0.56. Subject areas: IMMUNOLOGY. tlooto lists 2,501 papers from this journal.
CiteScore
4.90
Scopus citation metric
SJR
0.835
SCImago rank
SNIP
0.56
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1750-743X
- eISSN
- 1750-7448
- Abbreviation
- IMMUNOTHERAPY-UK
- Publisher
- TAYLOR & FRANCIS LTD
- Country
- United Kingdom
Web of Science categories
SCIEIMMUNOLOGY
Scopus ASJC categories
2403 Immunology2723 Immunology and Allergy2730 Oncology
Keywords
Immunology
Papers in this journal
Recent papers
- Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional study.
2026
- A case report of breast cancer recurrence with cystitis: the impact of immune checkpoint inhibitor therapy on the incidence of cystitis.
2026
- Could immunotherapy be a feasible treatment option for patient's suffering from chronic epilepsy?
2026
- Recent advances in bispecific natural killer cell engagers for cancer immunotherapy.
2026
- Efficacy of first-line immune checkpoint inhibitors for recurrent/metastatic head and neck cancer: a systematic review and meta-analysis
2026
Most cited papers
- Immunotherapeutic implications of IL-6 blockade for cytokine storm.
2016 · 637 citations
- Tumor-associated macrophages: implications in cancer immunotherapy.
2017 · 311 citations
- Toll-like receptor agonists in cancer therapy
2009 · 296 citations
- Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.
2010 · 237 citations
- Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
2020 · 203 citations